UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters

Biological and Pharmaceutical Bulletin, 2018/01/01, Vol.41(1), pp.47-56

2018

Volltextzugriff (PDF)

Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma

International journal of molecular sciences, 2020-12, Vol.21 (24), p.9705

2020

Volltextzugriff (PDF)

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

Cancer medicine (Malden, MA), 2021-06, Vol.10 (12), p.3873-3885

2021

Volltextzugriff (PDF)

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis

Therapeutic advances in medical oncology, 2022-01, Vol.14, p.17588359221142786-17588359221142786

2022

Volltextzugriff (PDF)

Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211166-17588359221116603

2022

Volltextzugriff (PDF)

Successful Treatment of Primary Pulmonary Angiosarcoma

Chest, 2003-12, Vol.124 (6), p.2397-2400

2003

Volltextzugriff (PDF)

Interstitial Lung Disease in Japanese Patients with Lung Cancer: A Cohort and Nested Case-Control Study

American journal of respiratory and critical care medicine, 2008-06, Vol.177 (12), p.1348-1357

2008

Volltextzugriff (PDF)

Prospective study for usefulness of circulating-free DNA on prediction of third generation EGFR tyrosine kinase inhibitors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21510-e21510

2020

Volltextzugriff (PDF)

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases

Anticancer research, 2019-02, Vol.39 (2), p.923-931

2019

Volltextzugriff (PDF)

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer : Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters

Biological and Pharmaceutical Bulletin, 2018-01, Vol.41 (1), p.47-56

2018

Volltextzugriff (PDF)

Abstract 5481: Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5481-5481

2015

Volltextzugriff (PDF)

Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small cell lung cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19104-e19104

2015

Volltextzugriff (PDF)

Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer

Pharmacogenomics, 2012-04, Vol.13 (5), p.615-624

2012

Volltextzugriff (PDF)

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

Therapeutic advances in medical oncology, 2021, Vol.13, p.1758835921998588-1758835921998588

2021

Volltextzugriff (PDF)

Abstract 5459: Association of CYP1A1 and CYP3A5 polymorphisms with pharmacokinetics of erlotinib in patients with non-small cell lung cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5459-5459

2011

Volltextzugriff (PDF)

Abstract 3588: Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3588-3588

2010

Volltextzugriff (PDF)

Association of

Pharmacogenomics, 2012-04, Vol.13 (5), p.615-624

2012

Volltextzugriff (PDF)

A Case of Mediastinal Abscess and Pericarditis Complications After Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

The Journal of the Japan Society for Respiratory Endoscopy, 2011/03/25, Vol.33(2), pp.109-113

2011

Volltextzugriff (PDF)

Treatment of a Primary Pulmonary Angiosarcoma

Chest, 2004-07, Vol.126 (1), p.318-318

2004

Volltextzugriff (PDF)

Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3329-3334

1998

Volltextzugriff (PDF)

P2-304: Multi-institutional phase ii study of carboplatin/gemcitabine combination chemotherapy in elderly patients (Pts) with advanced non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S693-S693

2007

Volltextzugriff (PDF)

A Case of Extranodal Marginal Zone Lymphoma in the Chest Wall

Haigan, 2010, Vol.50(4), pp.371-376

2010

Volltextzugriff (PDF)

Treatment of a Primary Pulmonary Angiosarcoma

Chest, 2004-07, Vol.126 (1), p.317-318

2004

Volltextzugriff (PDF)

P-677 Intrapleural hypotonic cisplatin treatment (HPT) for malignant pleural effusion in 80 patients with non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S263-S263

2003

Volltextzugriff (PDF)

超音波気管支鏡ガイド下針生検後に縦隔膿瘍,心膜炎を合併した1例

気管支学, 2011/03/25, Vol.33(2), pp.109-113

2011

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)

Sprache

Englisch
(25)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Humans
(13)
Life Sciences & Biomedicine
(13)
Female
(10)
Male
(10)
Lung Cancer
(9)
Lung Neoplasms - Drug Therapy
(8)
Oncology
(8)
Aged
(7)
Middle Aged
(7)
Adult
(6)
Chemotherapy
(6)
Targeted Cancer Therapy
(6)
Erlotinib
(5)
Lung Neoplasms - Genetics
(5)
Non-Small Cell Lung Carcinoma
(5)
Patients
(5)
Radiation Therapy
(5)
Aged, 80 And Over
(4)
Antineoplastic Agents - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters

Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis

Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)

Successful Treatment of Primary Pulmonary Angiosarcoma

Interstitial Lung Disease in Japanese Patients with Lung Cancer: A Cohort and Nested Case-Control Study

Prospective study for usefulness of circulating-free DNA on prediction of third generation EGFR tyrosine kinase inhibitors

Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases

Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer : Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters

Abstract 5481: Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer

Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small cell lung cancer

Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

Abstract 5459: Association of CYP1A1 and CYP3A5 polymorphisms with pharmacokinetics of erlotinib in patients with non-small cell lung cancer

Abstract 3588: Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Association of

A Case of Mediastinal Abscess and Pericarditis Complications After Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Treatment of a Primary Pulmonary Angiosarcoma

Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer

P2-304: Multi-institutional phase ii study of carboplatin/gemcitabine combination chemotherapy in elderly patients (Pts) with advanced non-small cell lung cancer (NSCLC)

A Case of Extranodal Marginal Zone Lymphoma in the Chest Wall

Treatment of a Primary Pulmonary Angiosarcoma

P-677 Intrapleural hypotonic cisplatin treatment (HPT) for malignant pleural effusion in 80 patients with non-small cell lung cancer (NSCLC)

超音波気管支鏡ガイド下針生検後に縦隔膿瘍,心膜炎を合併した1例

Suchergebnisse filtern